Immunovant Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, Immunovant stock has a consensus rating of "Buy" and an average price target of $44. The average 1-year stock price forecast is 28.84% higher than the current stock price, while the lowest is $24 (-29.72%) and the highest is $66 (+93.27%).

Price Target: $44 (+28.84%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$24	$44	$44	$66
Change	-29.72%	+28.84%	+28.84%	+93.27%

Analyst Ratings

The average analyst rating for Immunovant stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	3	3	3	3
Buy	2	2	2	2	2	2
Hold	5	4	4	4	4	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	9	9	9	9	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Danielle Brill Truist Securities	Truist Securities	Hold Maintains $23 → $30	Hold	Maintains	$23 → $30	-12.15%	May 22, 2026
Jason Gerberry B of A Securities	B of A Securities	Strong Buy Maintains $32 → $43	Strong Buy	Maintains	$32 → $43	+25.92%	May 21, 2026
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $35 → $40	Strong Buy	Maintains	$35 → $40	+17.13%	May 21, 2026
Corinne Johnson Goldman Sachs	Goldman Sachs	Hold Maintains $29 → $32	Hold	Maintains	$29 → $32	-6.30%	Apr 15, 2026
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $35	Strong Buy	Reiterates	$35	+2.49%	Feb 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

39.72M

EPS This Year

-2.67

from -2.77

EPS Next Year

-2.73

from -2.67

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027	Mar 31, 2028
Revenue	-	-	-	-	-	-	39.72M
Revenue Growth	-	-	-	-	-	-	-
EPS	-1.43	-1.71	-1.88	-2.73	-2.77	-2.67	-2.73
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	17	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2027	2028
High	n/a	236.4M
Avg	n/a	39.7M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2027	2028
High	-2.31	-1.55
Avg	-2.67	-2.73
Low	-3.29	-3.76

EPS Growth

EPS Growth	2027	2028
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.